In an oral presentation today, the company shared continued progress in increasing the diversity of participants enrolled in the BASECAMP-1 nationwide prescreening study for all Tmod™ CAR T-cell ...

Recent Highlights In November 2024, Elicio presented a poster, “AMPLIFY-7P Phase ... targeting p53 and BRAF mutations. In July 2024, a $11.5M underwritten public offering was completed and, in August, ...

The poster features ... duo debuted on July 6, 2020, with the mini-album, ‘Monster.’ Apart from being active in the music ...

Since Disneyland’s opening day, Disney’s animated films have been a key part of the theme parks, from timeless classics like Peter Pan's Flight and Mr. Toad's Wild Ride to modern marvels like Tiana's ...

Sonos (SONO) stocks is moving higher, after the audio equipment maker reported fourth-quarter financial results ...

We are encouraged to see that none of the 16 patients on the treatment arm relapsed, including five patients at least one-year post-transplant as of the July 8 th abstract ... CDMO in 2025. The ...

In November 2024 we received FDA Breakthrough Device Designation for the SCD for use in chronic dialysis, our first such designation for a chronic indication. This is our fourth FDA award of ...

SeaStar Medical Holding Corporation (Nasdaq: ICU) ("SeaStar Medical" or the "Company"), a commercial-stage medical device company developing proprietary solutions ...

The Terminator,' 'Seven Samurai,' 'Suspiria' and Criterion's 40th anniversary boxed set are among the best physical media releases in November.

A broken business model exacerbated by a collapse in influence has the Fourth Estate entering another Trump term in deep ...

Q3 2024 Earnings Call Transcript November 13, 2024 Operator: Greetings, and welcome to the Acurx Pharmaceuticals, Inc. Third ...

Stay updated on Beam Therapeutics Inc.'s latest advancements in Sickle Cell Disease and alpha-1 antitrypsin deficiency treatments. Click for my BEAM stock update.